Gender-Affirming Hormone Therapy for Breast Cancer in Transgender and Gender-Diverse Individuals: Unresolved and Unaddressed Issues
Mayo Clin Proc
.
2025 Jan;100(1):26-29.
doi: 10.1016/j.mayocp.2024.10.002.
Epub 2024 Dec 5.
Authors
Sanjna Rajput
1
,
Aminah Jatoi
2
,
Caroline Davidge-Pitts
3
,
Elizabeth J Cathcart-Rake
2
Affiliations
1
Mayo Clinic School of Graduate Medical Education, Internal Medicine Residency. Electronic address:
[email protected]
.
2
Department of Oncology, Mayo Clinic, Rochester, MN, USA.
3
Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN, USA.
PMID:
39641711
PMCID:
PMC11700775
(available on
2026-01-01
)
DOI:
10.1016/j.mayocp.2024.10.002
No abstract available
Grants and funding
K07 AG076401/AG/NIA NIH HHS/United States
K12 HD065987/HD/NICHD NIH HHS/United States
K23 MD019644/MD/NIMHD NIH HHS/United States